PHARMAMAMAMAMAPREPREPARACACACACACACACACACACACACACACAC1R,4R)-6'-PHPHPHPOPON,N-DIDIMITHEL-4-PHPHPHPHPHPHPHYYYYYL-4',9-D-3-HCCYACACACACACACACACACACACACACACACACACACACACACACACO-1,1,1'-1'-1,4,4,BBD THETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHETHEDEFINITIONS

摘要

The invention concerns a pharmaceutical formulation containing the first pharmacologically active ingredient selected from (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrene[3, 4-b]indole]-4-amine and its normally accepted salts and a second pharmacologically active ingredient selected from gabapentinoids and their normal acceptable salts.